Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06140134 · ClinicalTrials.gov registry record
Liver Transplantation in Intrahepatic Cholangiocarcinoma
A clinical trial of Intrahepatic Cholangiocarcinoma and Cholangiocarcinoma, Intrahepatic, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- 30
- Enrollment target
- 2
- Study locations
NCT06140134: Recruiting study of Intrahepatic Cholangiocarcinoma and Cholangiocarcinoma, Intrahepatic, sponsored by Rutgers, The State University of New Jersey.
NCT06140134 is a study of Intrahepatic Cholangiocarcinoma and Cholangiocarcinoma, Intrahepatic that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 30 participants, below the 134-participant average among 17 other Intrahepatic Cholangiocarcinoma trials with a reported enrollment target (78% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06140134, a study of Intrahepatic Cholangiocarcinoma and Cholangiocarcinoma, Intrahepatic, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
The aim of the current study is to determine the potential efficacy of liver transplantation in the form of patients' overall survival (OS) after neoadjuvant systemic therapy in patients with biologically responsive locally advanced non-metastatic intrahepatic cholangiocarcinoma (iCCA) in comparison to patients historically treated with chemotherapy alone.
Primary Outcome
5-year ORS is the length of time that patients diagnosed with locally advanced non-metastatic intrahepatic cholangiocarcinoma (iCCA) treated with neoadjuvant systemic therapy followed by liver transplant (LT) are still alive post-LT.
Conditions Studied
Interventions
- PROCEDURE Liver Transplant
Study Locations (2)
New Jersey
- Rutgers New Jersey Medical School - Newark
- University Hospital - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-12-15 |
| Est. Completion | 2029-11 |
What NCT06140134 shows while recruiting
NCT06140134 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 134-participant average among 17 other Intrahepatic Cholangiocarcinoma trials with a reported enrollment target (78% lower).
The record links to 2 conditions, with Intrahepatic Cholangiocarcinoma appearing as the primary indexed condition, and to 1 intervention - of which Liver Transplant is the first listed.
NCT06140134 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT06140134 about?
NCT06140134 is a clinical study titled "Liver Transplantation in Intrahepatic Cholangiocarcinoma". The aim of the current study is to determine the potential efficacy of liver transplantation in the form of patients' overall survival (OS) after neoadjuvant systemic therapy in patients with biologically responsive locally advanced non-metastatic intrahepatic cholangiocarcinoma (iCCA) in comparison...
What is the current status of trial NCT06140134?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2023-12-15. Estimated completion is 2029-11.
What conditions does trial NCT06140134 study?
This clinical trial studies the following conditions: Intrahepatic Cholangiocarcinoma, Cholangiocarcinoma, Intrahepatic.
What interventions are being tested in trial NCT06140134?
The interventions under investigation include: Liver Transplant (PROCEDURE).
Who is sponsoring clinical trial NCT06140134?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06140134 being conducted?
This trial has 2 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intrahepatic Cholangiocarcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06140134's enrollment target sits among peer trials
30 15th of 17 higher than 3 of 17 other Intrahepatic Cholangiocarcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Intrahepatic Cholangiocarcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
RECRUITING
-
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
RECRUITING · Phase 1
-
The Purpose of This Research Study is to See if Combining Gemcitabine, Cisplatin and Durvalumab Chemotherapy Treatments With a Direct Tumor Therapy Yittrium-90 (Y-90) Will Work Better Together to Shrink Tumors and Control Cancer
RECRUITING · Phase 2
-
A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement
RECRUITING · Phase 2
-
REGULUS: MRI-guided Adaptive SABR for Liver Cancers
RECRUITING · Phase 2
-
Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI